TSLA News Alert Tesla Motors (TSLA) 219.31 01/03/2015 14:22:

New Post Public Reply Private Reply Replies (0) Message Board

Jan 3, 2015 at 3:22 PM

Tesla Motors (TSLA) 219.31 $TSLA

Tesla: The Car Of The Future And The Good Investment Of The Past
Edward Vranic, CFA - at Seeking Alpha - 2 hrs 6 mins ago

TSLA: 219.31 (-3.10), F: 15.36 (-0.14), GM: 34.84 (-0.07), TM: 125.67 (+0.19), HMC: 29.59 (+0.07)

Berkshire, Buffett, and Beyond: Warren’s Successor May Be a Surprise
Rex Moore, The Motley Fool - Motley Fool - Sat Jan 03, 9:00AM CST
Berkshire without Buffett. Hard to imagine, but what will it look like? Hopefully it's a question that won't need to be answered for many years. But at some point Warren Buffett will no longer being piloting Berkshire Hathaway , and the identity...
TSLA: 219.31 (-3.10)

CES 2015 Preview: What Is NVIDIA Corporation Planning to Unveil?
Steve Symington, The Motley Fool - Motley Fool - Sat Jan 03, 8:48AM CST
The widely anticipated 2015 Consumer Electronics Show kicks off in Las Vegas on Tuesday, Jan. 6. But graphics chip specialist NVIDIA is getting the party started early -- again. NVIDIA this week announced it will hold a press event on Sunday...
TSLA: 219.31 (-3.10), GOOGL: 529.55 (-1.11), GOOG: 524.81 (-1.59), NVDA: 20.13 (+0.08)

Tesla Motors
at Investor's Business Daily - Fri Jan 02, 5:39PM CST
Tesla Motors (TSLA) plans to open a sales and service center in Pittsburgh and expand its supercharger stations across Pa. after receiving approval from the gov't to open more dealerships. Shares fell 1.4% to 219.31. Tesla CEO Elon Musk filed for...
TSLA: 219.31 (-3.10)

After Yesterday's Decline of 1.41%, Tesla Motors Inc Offers Investors Better Value
Comtex SmarTrend(R) - Fri Jan 02, 3:37PM CST
Tesla Motors Inc (NASDAQ:TSLA) traded in a range yesterday that spanned from a low of $213.26 to a high of $223.25. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $221.40 on volume of 4.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TSLA: 219.31 (-3.10)

Tesla Motors at $215 with gas at $2.23
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 10:14AM CST

TSLA: 219.31 (-3.10)

Alibaba, Facebook Led Dual-Class 2014 Tech Stocks
at Investor's Business Daily - Fri Jan 02, 8:41AM CST
Alibaba Group Holding's (BABA) September IPO put dual-class stocks back in the spotlight, while Google, which already had a dual-class stock, in April created a new class of nonvoting stock with its stock split, creating a tri-class stock. Dual-class...
TSLA: 219.31 (-3.10), AMZN: 308.52 (-1.83), LNKD: 229.65 (-0.06), FB: 78.45 (+0.43), ZNGA: 2.73 (+0.07), YELP: 55.15 (+0.42), GRPN: 8.02 (-0.24), AAPL: 109.33 (-1.05), DISH: 72.27 (-0.62), BABA: 103.60 (-0.34)

Auto Stock Roundup: Tesla Offers Roadster Upgrade, GM Launches 2016 CTS-V - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 7:57AM CST
Tesla (TSLA) grabbed the headlines with news of an upgrade for its oldest vehicle, Roadster, and General Motors (GM) launched the 2016 Cadillac CTS-V.
TSLA: 219.31 (-3.10), F: 15.36 (-0.14), AAP: 158.56 (-0.72), GM: 34.84 (-0.07), TM: 125.67 (+0.19), HMC: 29.59 (+0.07)

Uphill Year Ahead For Traditional, New Energy Vehicles
Doug Young - at Seeking Alpha - Fri Jan 02, 3:52AM CST
Bottom line: Traditional car makers will suffer from weak sales growth and plunging margins in China in 2015 and into 2016, while EV makers will start the new year slow but could see improvement by the end of 2015. A flurry of headlines this week...
TSLA: 219.31 (-3.10), TM: 125.67 (+0.19)

What Are Tesla's Prospects For 2015?
ValueWalk - at Seeking Alpha - Fri Jan 02, 12:52AM CST
By Christopher Morris It has been an up and down year for Tesla Motors Inc (NASDAQ: TSLA ) Inc, and perhaps this is to be expected given the new and relatively volatile niche within which the electric car manufacturer operates. But even if it...
TSLA: 219.31 (-3.10)

Will Audi's Electric Q7 Cause Tesla's Model X Backlog To Evaporate?
Anton Wahlman - at Seeking Alpha - Thu Jan 01, 5:24PM CST

TSLA: 219.31 (-3.10)

3 Stocks I'd Never Short
Motley Fool Staff - Motley Fool - Thu Jan 01, 10:48AM CST
When investors short-sell a particular stock, they are betting its stock price will drop. This allows them to buy back the shares they are short at a lower price and pocket the difference. Short-selling can be incredibly rewarding if you're on the...
NFLX: 348.94 (+7.33), TSLA: 219.31 (-3.10), AMZN: 308.52 (-1.83)

Jim Cramer's 'Mad Money' Recap: Revisiting My Time-Tested Investing Rules
at The Street - Wed Dec 31, 6:00PM CST
As 2015 approaches it's time to revisit the most important investing rules Cramer has learned over these many years.
TSLA: 219.31 (-3.10)

Tesla (TSLA) to Enable Torque Sleep in Dual Motor Model S - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 2:30PM CST
Tesla Motors, Inc. (TSLA) is planning a software update for its dual motor Model S vehicles that will enable torque sleep in the cars.
TSLA: 219.31 (-3.10), DAN: 21.66 (-0.08), GNTX: 17.93 (-18.20), DLPH: 72.59 (-0.13)

Volkswagen Pushes 2014's Record Recall Tally Higher
at Investor's Business Daily - Wed Dec 31, 12:28PM CST
Volkswagen's (VLKAY) recall of 25,007 Jettas on Tuesday pushed the 2014 tally of U.S. auto recalls for defects even further above the estimated record 62 million-plus. Roughly half of all recalls for the year came from General Motors (GM), mainly for...
TSLA: 219.31 (-3.10), F: 15.36 (-0.14), GM: 34.84 (-0.07), TM: 125.67 (+0.19), FCAU: 11.69 (+0.11)

The Truth About Tesla's Gross Margin
Tech Talker - at Seeking Alpha - Wed Dec 31, 11:35AM CST

TSLA: 219.31 (-3.10)

Will Tesla (TSLA) Stock be Hurt Today by Falling Gas Prices?
at The Street - Wed Dec 31, 11:01AM CST
Tesla (TSLA) shares are climbing after the company provided a detailed look at its vehicles driving ranges in a blog post yesterday.
TSLA: 219.31 (-3.10)

Why Falling Oil Prices Won't Hurt Tesla
The MKeyboard Advisor - at Seeking Alpha - Wed Dec 31, 9:54AM CST

TSLA: 219.31 (-3.10)

Why Tesla Needs To Be More Like Apple
Mark Hibben - at Seeking Alpha - Wed Dec 31, 9:48AM CST

TSLA: 219.31 (-3.10), AAPL: 109.33 (-1.05)

Warnings signs emerge on Chinese automobile market
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 8:04AM CST

KNDI: 13.04 (-0.97), TSLA: 219.31 (-3.10), F: 15.36 (-0.14), GM: 34.84 (-0.07), TM: 125.67 (+0.19), HMC: 29.59 (+0.07), TTM: 43.84 (+1.56)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...